BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Condition:   Multiple Myeloma Intervention:   Biological: GC012F injection Sponsors:   Shanghai Changzheng Hospital;   Gracell Biotechnology Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials